Cardiovascular disease in diabetic patients.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Medical clinics of North America

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0025-7125(05)70208-XPMID 10685129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factorin

  2004cited by this paper
• Diabetes and cardiovascular disease

  2000cited by this paper
• Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

  1999cited by this paper
• Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

  1999cited by this paper
• The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Medical management of atherosclerosis

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.

  1998cited by this paper
• Impact of Diabetes on Mortality After the First Myocardial Infarction

  1998cited by this paper
• Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

  1998cited by this paper
• Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.

  1998cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cited by this paper
• Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

  1998cited by this paper
• Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes.

  1998cited by this paper
• The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Aspirin therapy in diabetes.

  1997cited by this paper
• Aspirin Therapy in Diabetes: American Diabetes Association

  1997cited by this paper
• Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.

  1997cited by this paper
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

  1997cited by this paper
• Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

  1997cited by this paper
• Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study.

  1997cited by this paper
• Aspirin Therapy in Diabetes

  1997cited by this paper
• Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.

  1996cited by this paper
• Insulin Sensitivity and Atherosclerosis

  1996cited by this paper
• Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

  1996cited by this paper
• The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization

  1996cited by this paper
• Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

  1996cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association.

  1995cited by this paper
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

  1995cited by this paper
• From Diagnosis and Classification to Complications and Therapy: DCCT Part II?

  1994cited by this paper
• From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial.

  1994cited by this paper
• NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects

  1994cited by this paper
• Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groups

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non‐Insulin‐Dependent Diabetes

  1993cited by this paper
• Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non-insulin-dependent Diabetes

  1993cited by this paper
• Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study

  1992cited by this paper
• Hyperglycemia, Diabetes, and Vascular Disease

  1992cited by this paper
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

  1992cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment

  1992cited by this paper
• Is hyperglycemia associated with cardiovascular disease? The Framingham Study.

  1991cited by this paper
• Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

  1990cited by this paper
• Insulin and atheroma. 20-yr perspective.

  1990cited by this paper
• Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

  1989cited by this paper
• Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.

  1989cited by this paper
• Coagulation Factor VII and Plasma Triglycerides

  1989cited by this paper
• Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease — putative association via common antecedents; further evidence from the whitehall study

  1988cited by this paper
• Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

  1988cited by this paper
• Lipids, glucose intolerance and vascular disease: the Framingham Study.

  1985cited by this paper
• Epidemiology of sudden death: insights from the Framingham Study.

  1985cited by this paper
• Lipids, glucose intolerance and vascular disease: the Framingham Study.

  1985cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes

  1984cited by this paper
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study

  1983cited by this paper
• Plasma lipids and diabetes mellitus in an adult community.

  1982cited by this paper
• Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population

  1980cited by this paper
• Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

  1979cited by this paper
• Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

  1979cited by this paper
• Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

  1979cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper
• Insulin and atheroma.

  1969cited by this paper

• Ten-Year Cardiovascular Risk as Predicted by the QRISK®3 Calculator in Diabetic Patients Attending a Tertiary Care Teaching Hospital in Central India and Its Application to Stratify Statin Over-Users and Under-Users

  2023cites this paper
• Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study

  2022cites this paper
• Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism

  2021cites this paper
• Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction.

  2020cites this paper
• Serum Levels of Some Inflammatory Markers in Alloxan- Induced Diabetic Rats Treated with Aqueous Leaf Extract of Terminalia catappa and Exogenous Insulin

  2019cites this paper
• Correlation between Inflammatory Marker and Glycemic Control in Patients with Ischemic Heart Disease

  2018cites this paper
• Association of C- Reactive Protein and HbA1c in the Severity of Coronary Artery Disease in Patients with Ischemic Heart Disease

  2018cites this paper
• The Prevention and Treatment of Type 2 Diabetes Mellitus with a Plant-Based Diet

  2017cites this paper
• The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.

  2017cites this paper
• Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.

  2016cites this paper
• CRP and Diabetes: Sugar Is Not So Sweet

  2016cites this paper
• The Prevention and Treatment of Type 2 Diabetes Mellitus with a Plant-Based Diet 1 .

  2016cites this paper
• Biology of C Reactive Protein in Health and Disease

  2016cites this paper
• Comparison of the effects of canola oil and rice bran oil consumption on oxidative stress and blood pressure in postmenopausal type 2 diabetic women

  2015cites this paper
• PERFIL CLÍNICO DE PACIENTES DE UM PROGRAMA DE REABILITAÇÃO CARDÍACA QUE APRESENTAM RISCO DE TER DIABETES

  2015cites this paper
• ROLE OF HBA1C AND HS - CRP IN TYPE 2 DIABETES MELLITUS WITH CARDIOVASCULAR DISEASES

  2015cites this paper
• Diabetic Mellitus as Risk Factor Cardiovascular Disease in Province of Diyala

  2015cites this paper
• Atypical presentation of acute and chronic coronary artery disease in diabetics.

  2014cites this paper
• STUDY OF SERUM hs-CRP IN TYPE 2 DIABETIC PATIENTS *

  2014cites this paper
• Atherosclerotic Cardiovascular Disease

  2012cites this paper
• A Comparative study of Magnesium, C-reactive protein and lipids profile in Diabetic with Complication

  2012cites this paper
• PROGRAMA DE EXERCÍCIOS FÍSICOS: ANÁLISE DOS FATORES DE RISCO CARDIOVACULARES E BIOMARCADORES DE INFLAMAÇÃO E ESTRESSE OXIDATIVO EM DIABÉTICAS EXERCITADAS E NÃO EXERCITADAS

  2011cites this paper
• NIVELES DE PROTEÍNA C REACTIVA EN PACIENTES CON DIABETES MELLITUS TIPO 2, EN RELACIÓN AL GRADO DE CONTROL GLICÉRICO, EN EL ESTADO NUEVA ESPARTA, VENEZUELA

  2010cites this paper
• Coronary Artery Disease and Cardiomyopathy

  2010cites this paper
• THE EFFECTS OF VITAMIN E TREATMENT ON TRACHEAL REACTIVITY AND SOME BIOCHEMICAL PARAMETERS IN DIABETIC RATS DİYABETİK SIÇANLARDA, VİTAMİN E TEDAVİSİNİN TRAKEAL

  2009cites this paper
• TESI DI DOTTORATO DI RICERCA IN Scienze dell'Alimentazione e della Nutrizione XXII CICLO Coordinatore: Prof. Franco Contaldo "Infiammazione subclinica associata ad obesità e/o diabete di tipo 2: meccanismi patogenetici e possibili strategie di terapia nutrizionale"

  2009cites this paper
• PPARs in Atherosclerosis

  2008cites this paper
• Impact of telephonic interventions on glycosylated hemoglobin and low-density lipoprotein cholesterol testing.

  2007cites this paper
• Hyperglycemia promotes microinflammation as evaluated by C-reactive protein in the very elderly.

  2007cites this paper
• Diabetes mellitus and non-ST elevation myocardial infarction in Thai ACS Registry.

  2007cites this paper
• Diabetes, Inflammation, and Functional Decline in Older Adults

  2006cites this paper
• Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome

  2006cites this paper
• Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

  2005cites this paper
• Stroke prevention, treatment, and rehabilitation in sub-saharan Africa.

  2005cites this paper
• Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.

  2004cites this paper
• Efecte de la Peroxidació Lipídica sobre la Inflamació i la Trombosi

  2004cites this paper
• C-reactive protein and glycemic control in adults with diabetes.

  2003cites this paper
• Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women.

  2003cites this paper
• Fatty acids modulate the effect of darglitazone on macrophage CD36 expression

  2003cites this paper
• n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.

  2003cites this paper
• Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of diabetic rat myocardium.

  2003cites this paper
• Anesthesia for patients with diabetes mellitus

  2002cites this paper
• C-reactive protein, diabetes, and attendance at religious services.

  2002cites this paper
• [Cardiovascular risk and glucose metabolism: agreements and discrepancies between the WHO-85 and ADA-97 classifications].

  2002cites this paper
• Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.

  2002cites this paper
• Diabetes and cardiovascular disease.

  2002cites this paper
• Clinical Trial Evidence for Cardiovascular Risk Reduction in Type 2 Diabetes

  2002cites this paper
• Cardiovascular disease risk and glucose metabolism: agreement and discrepancies between the WHO-85 and ADA-97 classifications

  2002cites this paper
• Riesgo cardiovascular y metabolismo de la glucosa: acuerdos y discrepancias entre las clasificaciones OMS-85 y ADA-97

  2002cites this paper
• Apomorphine SL in the treatment of erectile dysfunction

  2002cites this paper
• Quality of care and diabetes mellitus

  2001cites this paper
• Evidence for a circulating islet cell growth factor in insulin-resistant states

  2001cites this paper
• Diabetes Disease Management: Past, Present, and Future

  2001cites this paper
• Genetic models of Insulin Resistance:Alterations in β-cell biology

  2001cites this paper
• Using thiazolidinediones: rosiglitazone and pioglitazone in clinical practice.

  2001cites this paper
• Antihypertensive treatment of patients with diabetes and hypertension.

  2001cites this paper
• Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium

  2000cites this paper
• The challenge of diabetes management.

  2000cites this paper
• The clinical implications of insulin resistance.

  2000cites this paper
• The challenge of diabetes management.

  2000cites this paper
• Diabetes and cardiovascular disease

  2000cites this paper
• C-Reactive Protein and Glycemic Control in Adults With Diabetes

  year unknowncites this paper